Annovis Bio
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Annovis Bio and other ETFs, options, and stocks.About ANVS
Annovis Bio, Inc. is a clinical stage drug platform company, which engages in the development of drugs which aim to treat neurodegenerative diseases such as Alzheimer's (AD) and Parkinson's (PD). Its lead product candidate, Buntanetap, is designed to address AD, PD, and potentially other chronic neurodegenerative diseases.
CEOMaria-Luisa Maccecchini
CEOMaria-Luisa Maccecchini
Employees5
Employees5
HeadquartersMalvern, Pennsylvania
HeadquartersMalvern, Pennsylvania
Founded2008
Founded2008
Employees5
Employees5
ANVS Key Statistics
Market cap129.97M
Market cap129.97M
Price-Earnings ratio-2.82
Price-Earnings ratio-2.82
Dividend yield—
Dividend yield—
Average volume406.72K
Average volume406.72K
High today$12.58
High today$12.58
Low today$11.58
Low today$11.58
Open price$12.27
Open price$12.27
Volume249.46K
Volume249.46K
52 Week high$23.89
52 Week high$23.89
52 Week low$5.42
52 Week low$5.42